Leukemia

Leukemia is a malignant clonal disease of hematopoietic stem cells, and its pathogenesis is complex and involves biological, physical, chemical, genetic and other blood disease factors. Leukemia cells in bone marrow and other hematopoietic tissues proliferate and multiply uncontrollably, inhibit normal hematopoiesis, and even leak into other organs. Acute myeloid leukemia is the most common type, and the incidence of acute leukemia is different from that of chronic leukemia: acute myeloid leukemia is more common in adults, and acute lymphoblastic leukemia is more common in children.

Overview of Leukemia

According to the clinical symptoms of the disease, the degree of the disease is different and there are no typical symptoms in the early stage of the disease like common diseases. The patient may have sudden high fever or severe bleeding in acute leukemia. Chronic progression is slow, and the patient may have anemia and bleeding symptoms, as well as enlarged lymph nodes and spleen, abnormal proliferation of lymphocyte cells, etc. Leukemia is not contagious, and the common causes are viral infections, immune dysfunction, long-term exposure to physical and chemical factors, unhealthy lifestyle habits, and even caused by cancer treatment. The treatment methods of leukemia are also relatively multiple, such as molecular targeted drug therapy, chemotherapy, radiotherapy, blood or bone marrow transplantation and various adjuvant therapies for other symptoms. The prognosis after treatment is also different. Some patients can be controlled for a long time or even cured by active treatment, while others may have a recurrence of the disease or even continue to deteriorate. In terms of prevention, the specific pathogenesis has not been fully elucidated and there are no specific prevention measures at present, so only limited prevention can be carried out by reducing the stimulation of known risk factors.

Causes and Risk Factors

The exact cause of leukemia is not yet fully understood, but several risk factors have been identified. These measures include:

• Genetic mutations: Certain genetic mutations, such as those involving the Philadelphia chromosome in chronic myeloid leukemia, are closely related to the development of leukemia.
• Exposure to radiation and chemicals: High levels of radiation exposure, such as nuclear accidents or medical treatment, can increase the risk of leukemia. Similarly, exposure to certain chemicals, such as benzene, is associated with a higher incidence rate of disease.
• Family history: Having members of a leukemia family may increase a person's risk, although this is not a strong predictor.
• Age: The risk of leukemia increases with age, especially CLL and AML.

Despite the existence of these known risk factors, the majority of cases occur in individuals without identifiable risk factors, highlighting the complexity of the etiology of the disease

Treatment and Management

The treatment of leukemia varies depending on the type and stage of the disease. Common methods include:

• Chemotherapy: This is the most commonly used treatment for leukemia, involving the use of drugs to kill cancer cells.
• Radiation therapy: used to treat local areas of the body affected by leukemia.
• Targeted therapy: This method uses drugs that target specific molecules involved in the growth and survival of leukemia cells.
• Immunotherapy: This therapy utilizes the human immune system to combat cancer.
• Stem cell transplantation: This is typically used in patients with advanced or recurrent leukemia, where healthy stem cells are injected to restore normal blood cell production.